10x Genomics, Inc
Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$16.0M
24 notices · 379,037 sh
Oct 2025 to Oct 2026
Reported ·
$4,633,596
22 sales · 0 buys
Oct 2025 to Jun 2026
The two figures cover different periods.
14 of 22 reported sales carry the 10b5-1 box.
under a no plan named▼ salesize is dollars
Form 144 notices, newest first
2026-09-22Shehnaaz Suliman, Affiliate$452,689
2026-09-09ADAM TAICH, Chief Financial Officer$2,995,470
2026-09-03STUELPNAGEL JOHN R, Director$1,235,046
2026-08-26Serge Saxonov, Chief Executive Officer$2,206,654
2026-08-24Taich Adam, Chief Financial Officer$1,081,904
2026-08-24Shehnaaz Suliman, Affiliate$143,720
2026-08-24Saxonov Serge, Chief Executive Officer$1,168,774
2026-08-24Hindson Benjamin J., See Remarks$870,850
2026-08-14SARAH A POLONIUS-TEICHMANN, Director$129,902
2026-08-13SARAH A POLONIUS-TEICHMANN, Director$302,377
2026-08-11STUELPNAGEL JOHN R, Director$1,155,032
2026-06-16Shehnaaz Suliman, Affiliate$184,395
Form 4, 2026-06-18: sold 5,723 at $32.63The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 13, 2026. Form 4 ↗
2026-05-26Serge Saxonov, Chief Executive Officer$964,202
Form 4, 2026-06-24: sold 30,000 at $34.44The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025. Form 4 ↗
2026-05-22Taich Adam, Chief Financial Officer$290,706
Form 4, 2026-05-27: sold 15,098 at $24.44The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. Form 4 ↗
2026-05-22Saxonov Serge, Chief Executive Officer$442,957
Form 4, 2026-05-27: sold 28,893 at $24.54The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. Form 4 ↗
2026-05-22Hindson Benjamin J., See Remarks$232,732
Form 4, 2026-05-27: sold 11,595 at $24.44The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. Form 4 ↗
2026-03-02Serge Saxonov, Chief Executive Officer$910,694
Form 4, 2026-03-04: sold 16,152 at $22.73 Form 4 ↗
2026-02-25SARAH A POLONIUS-TEICHMANN, Director$147,108
Form 4, 2026-02-27: sold 7,579 at $19.41 Form 4 ↗
2026-02-23Taich Adam, Chief Financial Officer$176,318
Form 4, 2026-02-25: sold 8,968 at $18.58 Form 4 ↗
2026-02-23Saxonov Serge, Chief Executive Officer$194,376
Form 4, 2026-02-25: sold 9,632 at $18.58 Form 4 ↗
2026-02-23Hindson Benjamin J., See Remarks$159,269
Form 4, 2026-02-25: sold 7,826 at $18.58 Form 4 ↗
2025-11-24Taich Adam, Chief Financial Officer$207,462
Form 4, 2025-11-25: sold 11,888 at $19.00 Form 4 ↗
2025-11-24Saxonov Serge, Chief Executive Officer$240,181
Form 4, 2025-11-25: sold 13,261 at $19.00 Form 4 ↗